Cargando…
A novel compound heterozygous mutation of the SMARCAL1 gene leading to mild Schimke immune-osseous dysplasia: a case report
BACKGROUND: Schimke immune-osseous dysplasia (SIOD, OMIM 242900) is characterized by spondyloepiphyseal dysplasia, T-cell deficiency, renal dysfunction and special facial features. SMARCAL1 gene mutations are determined in approximately 50% of patients diagnosed with SIOD. CASE PRESENTATION: The cas...
Autores principales: | Liu, Shuaimei, Zhang, Mingchao, Ni, Mengxia, Zhu, Peiran, Xia, Xinyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745888/ https://www.ncbi.nlm.nih.gov/pubmed/29282041 http://dx.doi.org/10.1186/s12887-017-0968-8 |
Ejemplares similares
-
A novel compound heterozygous variant in SMARCAL1 leading to mild Schimke immune-osseous dysplasia identified using whole-exome sequencing
por: Wang, Li, et al.
Publicado: (2021) -
T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent
por: Marin, Ana V., et al.
Publicado: (2022) -
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
por: Santangelo, Luisa, et al.
Publicado: (2014) -
Podocytic infolding in Schimke immuno-osseous dysplasia with novel SMARCAL1 mutations: a case report
por: Xiong, Shiqiu, et al.
Publicado: (2020) -
A Case of Schimke Immunoosseous Dysplasia Caused by Large Deletion of SMARCAL1 Gene
por: Malhotra, Rakhi, et al.
Publicado: (2021)